Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Head and Neck Neoplasms 4 Stomatitis 3 Squamous Cell Carcinoma of Head and Neck 3 Laryngeal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Intraepithelial Lesions 2 Skin Neoplasms 2 Hematologic Neoplasms 2 Dyspareunia 2 Carcinoma, Hepatocellular 2 Carcinoma, Basal Cell 2 Warts 1 Vulvar Neoplasms 1 Vomiting 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Soft Tissue Neoplasms 1 Retinoblastoma 1 Radiodermatitis 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Papillomavirus Infections 1 Papilloma 1 Pain 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Gemcitabine 30 Mitomycin 25 BCG Vaccine 13 Docetaxel 10 Epirubicin 6 erdafitinib 5 durvalumab 5 dodecyl maltoside 5 Radiotherapy 5 Cystoscopy 5 apaziquone 4 ALT-803 4 tislelizumab 3 5-aminolevulinic acid hexyl ester 3 viscum album peptide 2 pembrolizumab 2 disitamab vedotin 2 avelumab 2 VB4-845 2 Therapeutics 2 Imiquimod 2 Hyaluronic Acid 2 Administration, Intravesical 2 1-phenyl-3,3-dimethyltriazene 2 vocimagene amiretrorepvec 1 valrubicin 1 tremelimumab 1 toripalimab 1 pirarubicin 1 pemigatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × Laser Therapy × Clear all

NCT05337397 2022-08-08

OPTIMA

Aarhus University Hospital

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡